Popular Q2 2024 Earnings Report $99.64 +0.93 (+0.94%) As of 01/17/2025 04:00 PM Eastern Earnings HistoryForecast Popular EPS ResultsActual EPS$2.46Consensus EPS $2.08Beat/MissBeat by +$0.38One Year Ago EPS$2.10Popular Revenue ResultsActual Revenue$1.09 billionExpected Revenue$751.57 millionBeat/MissBeat by +$336.64 millionYoY Revenue GrowthN/APopular Announcement DetailsQuarterQ2 2024Date7/24/2024TimeBefore Market OpensBPOP Upcoming EarningsPopular will be holding an earnings conference call on Tuesday, January 28 at 10:00 AM Eastern. Interested parties can register for or listen to the call or dial in at 929-458-6194 using passcode "527575". Conference Call ResourcesConference CallConference Call TranscriptSlide DeckPress ReleaseBPOP Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Popular Earnings HeadlinesBitcoin Set For Major Bullish Surge, Says Popular Crypto Analyst As BTC Crosses $100,000 Ahead Of Trump InaugurationJanuary 18 at 3:58 AM | benzinga.comPopular grocery chain recalls food due to non-food debris contamination: Return ASAPJanuary 17 at 10:01 PM | msn.comGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. January 18, 2025 | Crypto 101 Media (Ad)Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price NegotiationsJanuary 17 at 12:44 PM | benzinga.comOzempic, Wegovy and other new drugs are selected for Medicare’s price negotiationsJanuary 17 at 9:59 AM | financialpost.comOzempic, Wegovy and other new drugs are selected for Medicare’s price negotiationsJanuary 17 at 9:59 AM | financialpost.comSee More Popular Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Popular? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Popular and other key companies, straight to your email. Email Address About PopularPopular (NASDAQ:BPOP), through its subsidiaries, provides various retail, mortgage, and commercial banking products and services in Puerto Rico, the United States, and the British Virgin Islands. The company provides savings, NOW, money market, and other interest-bearing demand accounts; non-interest bearing demand deposits; and certificates of deposit. It also offers commercial and industrial, commercial multi-family, commercial real estate, and residential mortgage loans; consumer loans, including personal loans, credit cards, automobile loans, home equity lines of credit, and other loans to individual borrowers; construction loans; and lease financing comprising automobile loans/leases. In addition, the company provides investment banking, auto and equipment leasing and financing, broker-dealer, and insurance services; debit cards; and online banking services. Popular, Inc. was founded in 1893 and is headquartered in Hato Rey, Puerto Rico.View Popular ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings Interactive Brokers Group (1/21/2025)Netflix (1/21/2025)Capital One Financial (1/21/2025)HDFC Bank (1/21/2025)3M (1/21/2025)Prologis (1/21/2025)Charles Schwab (1/21/2025)Abbott Laboratories (1/22/2025)Amphenol (1/22/2025)GE Vernova (1/22/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
